U.S. Stem Cell Patents and Considerations for Reform
On March 9, 2009, President Obama signed an executive order removing restrictions on federal funding for research involving embryonic stem cells. Prior to the signing,
On March 9, 2009, President Obama signed an executive order removing restrictions on federal funding for research involving embryonic stem cells. Prior to the signing,
The controversial doctrine of inequitable conduct has once again garnered much attention in the patent law community due to the recent denial of certiorari by the US
Lee Hollaar is a professor of computer science at the University of Utah, where he teaches engineering and intellectual property law as well as networking
Justin Lim is a student at Osgoode Hall Law School (J.D. Class of 2010) and Student Director of the International Legal Partnership I’m very excited to
Pamela Samuelson is the Richard M. Sherman ‘74 Distinguished Professor of Law and Information at the University of California at Berkeley and is a member
Although a patent is typically seen as a right to exclude others, the willingness of American courts to automatically provide that right through a permanent